Home › Entities › academia › Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure

Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure

Research article (Journal of Translational Medicine, 2016) · cited 27× · AI/ML
academia openalex:W2296833987
Press Enter · cited answer in seconds

Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure

Summary

Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure is a scholarly article[1].

Key Facts

  • Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure's instance of is recorded as scholarly article[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure. Retrieved May 24, 2026, from https://4ort.xyz/entity/automation-of-cellular-therapy-product-manufacturing-results-of-a-split-validation-comparing-cd34-selection-of-periphera
MLA “Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/automation-of-cellular-therapy-product-manufacturing-results-of-a-split-validation-comparing-cd34-selection-of-periphera.
BibTeX @misc{4ortxyz_automation-of-cellular-therapy-product-manufacturing-results-of-a-split-validation-comparing-cd34-selection-of-periphera_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure}}, year = {2026}, url = {https://4ort.xyz/entity/automation-of-cellular-therapy-product-manufacturing-results-of-a-split-validation-comparing-cd34-selection-of-periphera}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure — https://4ort.xyz/entity/automation-of-cellular-therapy-product-manufacturing-results-of-a-split-validation-comparing-cd34-selection-of-periphera (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/automation-of-cellular-therapy-product-manufacturing-results-of-a-split-validation-comparing-cd34-selection-of-periphera · Last refreshed: